Two COVID-19 antivirals get FDA nod for emergency use
Unlike in the case of remdesivir, both the drugs — Pfizer’s paxlovid and Merck’s molnupiravir — are oral pills and so can be administered outside hospital settings. These drugs are…
Category: Pfizer
How the idea of vaccine protection changed in one year
On this day last year (December 11, 2020), Pfizer’s vaccine for COVID-19 was granted an emergency use authorisation, and exactly a week later, Moderna’s vaccine was granted an EUA. On…
Does the Omicron variant make a case for booster doses?
At a recent meeting, the National Technical Advisory Group on Immunisation maintained that it was not recommending a booster dose for any section of the population, priority groups included, in…
Restrictive voluntary license of COVID-19 antivirals compromises access, says Leena Menghaney
In an email, Leena Menghaney, South Asia Head of Médecins Sans Frontières’s Access Campaign, says that the voluntary license will exclude India from even supplying raw materials (active pharmaceutical ingredients)…
Pfizer’s antiviral Paxlovid is a major advancement potentially for all coronaviruses, says Gagandeep Kang
In an email, Dr. Gagandeep Kang, Professor of Microbiology at CMC Vellore explains the significance of paxlovid antiviral for treatment, its mode of action, and the need for a combination…
‘Pandemic far from over’ even as global death toll crosses five million
Effects of vaccination The speed at which the virus had killed people slowed down a bit since summer this year — it took nearly four months to add one more million deaths…
More studies show hybrid immunity provides better protection
Though 500 health-care workers with or without prior infection were vaccinated, those with hybrid immunity — natural immunity from an infection combined with the immunity provided by the vaccine — had…
Why three Nordic countries have suspended Moderna vaccine
A day later, Finland followed suit and paused the use of the Moderna vaccine in people younger than 30 years. Both Finland Health institute and the Swedish Public Health Agency…
Science Chronicle 